References
- Bergler W, Sadick H, Gotte K, Riedel F, Hörmann K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 2002;111:222–8.
- Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–7.
- Plauchu H, de Chadarévian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291–7.
- Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet a 2012;158A:1269–78.
- Albiñana V, Bernabeu-Herrero ME, Zarrabeitia R, Bernabéu C, Botella LM. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on endoglin and ALK1 expression in endothelial cells. Thromb Haemost 2010;103:525–34.
- Syed I, Sunkaraneni VS. Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia. J Laryngol Otol 2015;129:410–15.
- Yaniv E, Preis M, Shevro J, Nageris B, Hadar T. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia – a long-term clinical trial. Rhinology 2011;49:214–16.
- Harrison DF. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982;92:314–20.
- Bergler W, Götte K. Hereditary hemorrhagic telangiectasias: a challenge for the clinician. Eur Arch Otorhinolaryngol 1999;256:10–15.
- Bergler W, Riedel F, Baker-Schreyer A, Juncker C, Hörmann K. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 1999;109:15–20.
- Sadick H, Naim R, Oulmi J, Hörmann K, Bergler W. Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease. Otolaryngol Head Neck Surg 2003;129:233–8.
- Minami K, Haji T. Effect of topical estriol on the nasal mucosa in a patient with Osler’s Disease. Nihon Bika Gakkai Kaishi (Japanese J Rhinol) 2013;52:1–7.
- Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 2010;120:838–43.
- Lauritzen C. [Estrogen therapy in general practice. 1. Main effect of estrogen administration and estrogen deficiency; indications for estrogen treatment]. [Article in German]. Fortschr Med 1977;95:1132–40.
- Lievertz RW. Pharmacology and pharmacokinetics of estrogens. Am J Obstet Gynecol 1987;156:1289–93.
- Chang KJ, Lee TT, Linares-Cruz G, Fournier S, de Ligniéres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785–91.
- Koch HJ, Escher GC, Lewis JS. Hormonal management of hereditary hemorrhagic talangiectasia. J Am Med Assoc 1952;149:1376–80.
- Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 1981;209:393–6.
- Cignarella A, Paoletti R, Puglisi L. Direct effects of estrogen on the vessel wall. Med Res Rev 2001;21:171–84.
- Sadick H, Bergler WF, Oulmi-Kagermann J, Naim R, Sadick M, Hörmann K, et al. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia. Arch Med Res 2005;36:468–73.